For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Droperidol (Antiemetic (butyrophenone, D₂ antagonist)) – indications: PONV prophylaxis and treatment – adults, PONV prophylaxis and treatment – children from 2 y and adolescents (second-line agent). Weight-based dosing in mg and ml in the app, with sources.
Indications
- PONV prophylaxis and treatment – adults
- PONV prophylaxis and treatment – children from 2 y and adolescents (second-line agent)
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.